There are 717 resources available
43O - Phase III KEYNOTE-355 study of pembrolizumab (pembro) vs placebo (pbo) + chemotherapy (chemo) for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC): Results for patients (Pts) enrolled in Asia
Presenter: Mastura Md Yusof
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
44O - Pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-119 Asia-Pacific subpopulation
Presenter: Seock-Ah Im
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
45O - Abemaciclib plus fulvestrant in East Asian women with HR+, HER2- advanced breast cancer: Overall survival from MONARCH 2
Presenter: Chiun-Sheng Huang
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
46O - Neratinib + capecitabine (N+C) vs lapatinib + capecitabine (L+C) in Asians with HER2+ metastatic breast cancer (MBC) previously treated with two or more HER2-directed regimens: A Pan-Asian analysis of the phase III NALA trial
Presenter: Ming Shen Dai
Session: Proffered paper session on Breast cancer
Resources:
Abstract
Slides
Webcast
234O - Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1
Presenter: Michael Friedlander
Session: Proffered paper session on Gynaecological tumours
Resources:
Abstract
Slides
Webcast
235O - Efficacy and safety of Niraparib in Chinese Patients with Platinum-Sensitive Recurrent Ovarian Cancer (NORA) with Individualized Starting Dose: A Subgroup Analysis of A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
Presenter: Jianqing Zhu
Session: Proffered paper session on Gynaecological tumours
Resources:
Abstract
Slides
Webcast
236O - Olaparib (ola) plus bevacizumab (bev) as maintenance (mx) therapy in patients (pts) with newly diagnosed advanced ovarian carcinoma (OC): Japan subset of the PAOLA-1 trial
Presenter: Keiichi Fujiwara
Session: Proffered paper session on Gynaecological tumours
Resources:
Abstract
Slides
Webcast
237O - Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence for high-grade serous ovarian cancer patients with advanced disease
Presenter: Jing Li
Session: Proffered paper session on Gynaecological tumours
Resources:
Abstract
Slides
Webcast
238O - Deep learning magnetic resonance imaging radiomic predict platinum-sensitive in patients with epithelial ovarian cancer
Presenter: lei ruilin
Session: Proffered paper session on Gynaecological tumours
Resources:
Abstract
Slides
Webcast
265O - Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial
Presenter: Yihebali Chi
Session: Proffered paper and Mini oral mixed session on Head and neck
Resources:
Abstract
Slides
Webcast